Christopher Gibson, Chief Executive Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 80,390 shares at $4.16 ($334K) on 2025-11-19, disclosed to the SEC on 2025-11-19.
Scheduled sale ($334k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.14 | 40,390 | $167K | 50.1% |
| 2 | $4.16 | 40,000 | $166K | 49.9% |
| Total | $4.15 avg | 80,390 | $334K | 100% |
| Filing → |
| RXRX | SELL | 2026-05-08 | $135K | — | Filing → |
| RXRX | SELL | 2026-04-24 | $144K | — | Filing → |
| RXRX | SELL | 2026-04-08 | $124K | — | Filing → |